Integral Derivatives’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$498K Buy
7,600
+1,000
+15% +$71.5K 0.01% 391
2017
Q4
$479K Sell
6,600
-23,200
-78% -$1.63M 0.01% 730
2017
Q3
$2.3M Buy
29,800
+9,400
+46% +$753K 0.04% 277
2017
Q2
$1.6M Buy
20,400
+8,200
+67% +$675K 0.03% 358
2017
Q1
$1.01M Sell
12,200
-900
-7% -$75.5K 0.02% 519
2016
Q4
$1.08M Buy
+13,100
New +$1.08M 0.02% 487
2016
Q2
Sell
-30,000
Closed -$2.53M 1109
2016
Q1
$2.53M Sell
30,000
-30,000
-50% -$2.4M 0.08% 175
2015
Q4
$5.11M Sell
60,000
-18,000
-23% -$1.53M 0.13% 126
2015
Q3
$6.48M Buy
78,000
+53,000
+212% +$4.79M 0.18% 83
2015
Q2
$2.11M Sell
25,000
-48,000
-66% -$4.14M 0.06% 301
2015
Q1
$6.18M Sell
73,000
-35,800
-33% -$2.85M 0.13% 93
2014
Q4
$8.29M Buy
108,800
+49,700
+84% +$3.32M 0.14% 108
2014
Q3
$3.5M Sell
59,100
-15,700
-21% -$1.03M 0.06% 276
2014
Q2
$5.54M Buy
74,800
+64,800
+648% +$4.53M 0.1% 164
2014
Q1
$660K Sell
10,000
-16,800
-63% -$1.06M 0.01% 799
2013
Q4
$1.54M Buy
+26,800
New +$1.56M 0.02% 615

Other funds holding WBA

Integral Derivatives's WBA Position: Q4 2017 in Review

Integral Derivatives sold out of Walgreens Boots Alliance (WBA) in Q4 2017, closing a stake of 3,679 shares — an estimated $259K sold.

Integral Derivatives first reported a position in WBA in Q1 2014 and held it in 4 quarters. The position peaked at $2.78M in Q3 2015. 1,321 funds tracked by Wall St. Rank hold WBA as of Q4 2017.

  • Integral Derivatives reported no remaining Walgreens Boots Alliance position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 3,679 Walgreens Boots Alliance shares in Q4 2017, an estimated $259K.
  • Integral Derivatives first reported a position in Walgreens Boots Alliance in Q1 2014 and held it in 4 quarters.
  • Integral Derivatives's Walgreens Boots Alliance position peaked at $2.78M in Q3 2015.
  • 1,321 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.